在与左心脏病或慢性肺部疾病相关的PH中,皮肤下注射特雷普罗斯尼尔
Roela Sadushi-Koliçi1, Leila Alajbegovic1, Vladimir Gojic2
1Department of Internal Medicine II, Division of Cardiology Medical University of Vienna Vienna Austria.
Pulmonary circulation
|January 20, 2026
概括
皮下施用特雷普罗斯丁尼尔 (scTRE) 改善了由于左心病 (LHD-PH) 或慢性肺病 (CLD-PH) 导致的严重肺高血压 (PH) 患者的运动能力和功能类,具有适度的5年生存益处.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 与左心病 (LHD-PH) 和慢性肺病 (CLD-PH) 相关的肺高血压 (PH) 是常见的,但未得到充分治疗.
- 严重的右心力衰竭 (RHF) 病例预后不佳.
研究的目的:
- 评估皮下特雷普罗斯提尼尔 (scTRE) 在严重的LHD-PH和CLD-PH患有RHF的患者的疗效和安全性.
- 评估临床,心声回声,血液动力学和5年生存结果.
主要方法:
- 对90名严重LHD-PH/CLD-PHRHH患者进行前性队列研究,这些患者接受了scTRE治疗.
- 在基线和12个月时评估6分钟步行距离 (6MWD),世卫组织功能类 (WHO FC),mPAP和TAPSE/sPAP比率.
- 追踪了5年的生存期;基线PAWP分析了结果相关性.
主要成果:
- 在12个月后,在LHD-PH和CLD-PH组中观察到6MWD,WHO FC和mPAP的显著改善.
- 在CLD-PH患者中,TAPSE/sPAP比率有所改善.
- 中位数的scTRE剂量为30 ng/kg/min;5年生存率为38.6% (LHD-PH) 和49.7% (CLD-PH).
- 较低的基线PAWP (<12 mmHg) 与更好的结果相关.
结论:
- 开放标签的scTRE显示出临床相关的益处,并且在选择的严重LHD-PH和CLD-PH患有RHF的患者中耐受良好.
- scTRE为这种高风险人群提供了潜在的治疗选择,特别是那些基线PAWP较低的人群.
相关概念视频
01:22Chronic Obstructive Pulmonary Disease
2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K
01:25Chronic Kidney Disease I: Introduction
590
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
590
01:23Rheumatic Heart Disease I: Introduction
454
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
454
01:17Ischemic Heart Disease: Overview
3.0K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.0K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K